ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,995Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 122

$477K Total Retail Price of All Prescriptions

Rank: 18 out of 122

419 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

5% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 395 342 1 1
LISINOPRIL 379 313 2 2
OMEPRAZOLE 324 239 3 3
LEVOTHYROXINE SODIUM 309 294 4 4
FUROSEMIDE 261 213 5 5
METFORMIN HCL 218 165 6 14
WARFARIN SODIUM 217 147 7 9
METOPROLOL SUCCINATE 211 202 8 11
AMLODIPINE BESYLATE 186 162 9 7
HYDROCHLOROTHIAZIDE 166 143 10 6
METOPROLOL TARTRATE 149 140 11 8
HYDROCODONE-ACETAMINOPHEN 136 69 S3 12 16
ATENOLOL 134 130 13 10
ATORVASTATIN CALCIUM 127 117 14 13
RANITIDINE HCL 124 85 15 39
TAMSULOSIN HCL 123 111 16 26
ALLOPURINOL 120 94 17 33
FLUOXETINE HCL 118 88 18 38
PROAIR HFA 113 97 19 31
GABAPENTIN 109 93 20 12
LOSARTAN POTASSIUM 102 102 21 17
CITALOPRAM HBR 99 89 22 15
OXYCODONE-ACETAMINOPHEN 99 62 S2 22 41
ADVAIR DISKUS 93 77 24 34
SPIRIVA 92 79 25 29
PRAVASTATIN SODIUM 92 87 25 27
LOVASTATIN 84 82 27 28
POTASSIUM CHLORIDE 83 83 28 22
GLIPIZIDE 78 68 29 77
OXYCODONE HCL 78 48 S2 29 30
MORPHINE SULFATE ER 77 52 S2 31 42
TRAZODONE HCL 71 58 32 21
LANTUS SOLOSTAR 69 67 33 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 67 34 49
VERAPAMIL ER 66 61 35 95
PANTOPRAZOLE SODIUM 64 55 36 23
FINASTERIDE 64 64 36 76
LANTUS 61 45 38 36
PEN NEEDLE 58 56 39 98
KLOR-CON M20 58 32 39 67
TORSEMIDE 56 53 41 94
CALCITRIOL 52 52 42 168
DIOVAN 50 38 43 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.